UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.
Search Articles
The European respiratory journal, ISSN 0903-1936, 12/2015, Volume 46, Issue 6, pp. 1563 - 1576
Rifampin - analogs & derivatives | Public Health | HIV Infections - epidemiology | Humans | Latent Tuberculosis - epidemiology | Homeless Persons | Silicosis - epidemiology | Drug Users | Transplant Recipients | Tuberculin Test | Latent Tuberculosis - diagnosis | Latent Tuberculosis - drug therapy | Substance-Related Disorders - epidemiology | Health Personnel | Isoniazid - therapeutic use | Rifampin - therapeutic use | Emigrants and Immigrants | Antirheumatic Agents - therapeutic use | Antitubercular Agents - therapeutic use | World Health Organization | Risk Assessment | Comorbidity | Interferon-gamma Release Tests | Coinfection - epidemiology | Evidence-Based Medicine | Kidney Failure, Chronic - therapy | Mass Screening | Kidney Failure, Chronic - epidemiology | Disease Management | Radiography, Thoracic | Tumor Necrosis Factor-alpha - antagonists & inhibitors | Practice Guidelines as Topic | Prisoners | Renal Dialysis
Journal Article
Seminars in respiratory and critical care medicine, ISSN 1069-3424, 06/2018, Volume 39, Issue 3, pp. 271 - 285
Review Article | epidemiology | risk factors | tuberculosis | mortality | disease burden | latent infection | incidence | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Tuberculosis - epidemiology | World Health Organization | Humans | Risk Factors | Tuberculosis - complications | Cost of Illness | Incidence | HIV Infections - microbiology | Tuberculosis - therapy | Global Health - trends | Tuberculosis - prevention & control | Global Health - statistics & numerical data | HIV Infections - mortality | Index Medicus
Journal Article
Chest, ISSN 0012-3692, 2017, Volume 152, Issue 1, pp. 165 - 173
clinical management | epidemiology | diabetes | public health | tuberculosis | Respiratory System | Life Sciences & Biomedicine | Critical Care Medicine | General & Internal Medicine | Science & Technology | Tuberculosis - epidemiology | Tuberculosis - physiopathology | Comorbidity | Humans | Diabetes Mellitus - metabolism | Public Health - methods | Research | Mass Screening - methods | Tuberculosis - therapy | Diabetes Mellitus - physiopathology | Diabetes Mellitus - epidemiology | Diabetes Mellitus - therapy | Disease Management | Public Health - standards | Tuberculosis - metabolism | Complications and side effects | Care and treatment | Tuberculosis | Analysis | Diabetes | Epidemiology | Risk factors | Index Medicus | Abridged Index Medicus | NCD, noncommunicable disease | DM, diabetes mellitus | HbA1c, glycated hemoglobin | OGTT, oral glucose tolerance test | ART, antiretroviral therapy | LTBI, latent TB infection | MDR, multidrug resistant
Journal Article
The New England journal of medicine, ISSN 0028-4793, 05/2015, Volume 372, Issue 22, pp. 2127 - 2135
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Rifampin - analogs & derivatives | Antitubercular Agents - adverse effects | Drug Administration Schedule | Humans | Risk Factors | Latent Tuberculosis - epidemiology | Latent Tuberculosis - diagnosis | Isoniazid - administration & dosage | Latent Tuberculosis - drug therapy | Mycobacterium tuberculosis | Antitubercular Agents - administration & dosage | Latent Tuberculosis - etiology | Rifampin - administration & dosage | Drug Therapy, Combination | Practice Guidelines as Topic | Usage | Care and treatment | Tuberculin test | Tuberculosis | Diagnosis | Risk factors | Cost-benefit analysis | Latent infection | Infections | Pathogenesis | Epidemiology | Index Medicus | Abridged Index Medicus
Journal Article
Respirology (Carlton, Vic.), ISSN 1323-7799, 06/2018, Volume 23, Issue 6, pp. 567 - 575
ageing | mechanism | geriatric population | tuberculosis | Life Sciences & Biomedicine | Respiratory System | Science & Technology | Tuberculosis - epidemiology | Public Health | Tuberculosis, Pulmonary - metabolism | Comorbidity | Humans | Latent Tuberculosis - epidemiology | Oxidative Stress - immunology | Tuberculosis, Pulmonary - drug therapy | Mitochondria - metabolism | Tuberculosis - diagnosis | Australia - epidemiology | Tuberculosis - immunology | Latent Tuberculosis - metabolism | Aging - immunology | Asia - epidemiology | Latent Tuberculosis - drug therapy | Smoking - epidemiology | Diabetes Mellitus - epidemiology | Tuberculosis - drug therapy | Immunosenescence | Aged | Tuberculosis, Pulmonary - epidemiology | Aging - metabolism | Antitubercular Agents - therapeutic use | Tuberculosis | Tuberculosis in old age | Health aspects | Epidemiology | Oxidative stress | Mitochondria | Diabetes mellitus | Older people | Aging | Patients | Disease control | Public health | Smoking | Geriatrics | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 1/2007, Volume 44, Issue 1, pp. 94 - 102
HIV/AIDS | Antiretrovirals | HIV infections | Tuberculosis | HIV | Mycobacterium tuberculosis | Cohort studies | Latent tuberculosis | Infections | Tuberculin | Carts | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Tuberculosis - epidemiology | Prevalence | Humans | Tuberculin Test - methods | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Tuberculosis - diagnosis | Incidence | Tuberculosis - drug therapy | Tuberculosis - prevention & control | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination | Prevention | Antiviral agents | Care and treatment | Usage | Disease transmission | Demographic aspects | Tuberculin test | Diagnosis | Antiretroviral drugs | Preventive medicine | Drug therapy | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 2017, Volume 64, Issue 2, pp. 111 - 115
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Tuberculosis - epidemiology | Tuberculosis, Pulmonary - microbiology | Age Factors | Humans | Tuberculosis - microbiology | Tuberculosis - diagnosis | Latent Tuberculosis - diagnosis | Tuberculosis, Pulmonary - diagnosis | Adult | Latent Tuberculosis - microbiology | Tuberculosis - transmission | Child | Mycobacterium tuberculosis - genetics | Care and treatment | Adults | Diagnosis | Children | Mycobacterium tuberculosis | Health aspects | Disease prevention | Task forces | Tuberculosis | Clinical medicine | Medical diagnosis | Diagnostic tests | Index Medicus
Journal Article
Emerging infectious diseases, ISSN 1080-6040, 03/2011, Volume 17, Issue 3, pp. 488 - 494
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Tuberculosis - epidemiology | Humans | Risk Factors | Infection Control | Latent Tuberculosis - epidemiology | Tuberculosis - microbiology | Occupational Diseases - microbiology | Health Personnel - statistics & numerical data | Latent Tuberculosis - transmission | Incidence | Infectious Disease Transmission, Patient-to-Professional | Latent Tuberculosis - microbiology | Occupational Diseases - epidemiology | Tuberculosis - transmission | Medicine, Experimental | Medical research | Health care industry | Tuberculosis | Workers | Health aspects | Index Medicus | Tuberculosis and other mycobacteria | CME | health care workers | Research | systematic review | research
Journal Article
9.
Full Text
Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA
The Lancet infectious diseases, ISSN 1473-3099, 2017, Volume 17, Issue 10, pp. e327 - e333
Infectious Disease | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Tuberculosis - epidemiology | United States - epidemiology | Latent Tuberculosis - drug therapy | Time Factors | Humans | Latent Tuberculosis - epidemiology | Latent Tuberculosis - diagnosis | Antitubercular Agents - therapeutic use | Tuberculosis - pathology | Epidemiology | Health aspects | Tuberculosis | Virus diseases | Prevention | Medical research | Analysis | Medicine, Experimental | Homeless people | Health risks | Infections | Activation | Cost analysis | Disease control | Public health | Index Medicus
Journal Article
Clinical infectious diseases, ISSN 1058-4838, 3/2012, Volume 54, Issue 6, pp. 784 - 791
Tuberculosis | Infectious diseases | Mycobacterium tuberculosis | Nurses | Latent tuberculosis | Disease risk | Infections | Tuberculosis vaccine | ARTICLES AND COMMENTARIES | Reinfection | Epidemiology | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Biological and medical sciences | Medical sciences | Bacterial diseases | Human bacterial diseases | Tuberculosis and atypical mycobacterial infections | Tuberculosis - epidemiology | Prevalence | Prospective Studies | Humans | Risk Factors | Latent Tuberculosis - epidemiology | Latent Tuberculosis - pathology | Disease Progression | Incidence | Tuberculosis - pathology | Research | Risk factors | Gram-positive bacteria | Risk exposure | Health risk assessment | Index Medicus | and Commentaries
Journal Article